Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Pricing

Weight Loss Medications

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

A fresh approval plus a $499 cash offer signals a bid to widen access, blunt copycats.

Mounjaro Price Hike Triggers Stockpiling and Shift to Ozempic and Wegovy

U.S. and China Agree to 90-Day Tariff Suspension in Trade War De-escalation

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices